Aashka Hospitals Share Price
Sector: Healthcare Facilities
You have to be logged in to add this to Watchlist.
Login or Register
100.00 +4.00 (4.17%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
93.25
Today’s High
100.75
52 Week Low
88.15
52 Week High
126.55
Key Metrics
- Market Cap (In Cr) 234
- Beta 1.79
- Div. Yield (%) 0
- P/B 2.26
- TTM P/E 73.45
- Peg Ratio 8.92
- Sector P/E 22.44
- D/E 0
- Open Price 93.25
- Prev Close 96
Aashka Hospitals Analysis
Price Analysis
-
1 Week-1.79%
-
3 Months-6.8%
-
6 Month-12.53%
-
YTD-12.25%
-
1 Year-6.2%
Risk Meter
- 39% Low risk
- 39% Moderate risk
- 39% Balanced Risk
- 39% High risk
- 39% Extreme risk
Aashka Hospitals Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 22.65
- Selling/ General/ Admin Expenses Total
- 5.28
- Depreciation/ Amortization
- 2.95
- Other Operating Expenses Total
- 10.61
- Total Operating Expense
- 20.39
- Operating Income
- 2.26
- Net Income Before Taxes
- 3.87
- Net Income
- 3.27
- Diluted Normalized EPS
- 1.06
- Period
- 2025
- Total Assets
- 116.05
- Total Liabilities
- 16.51
- Total Equity
- 99.54
- Tangible Book Valueper Share Common Eq
- 42.54
- Period
- 2025
- Cashfrom Operating Activities
- 9.19
- Cashfrom Investing Activities
- -1.38
- Cashfrom Financing Activities
- -7.2
- Net Changein Cash
- 0.61
- Period
- 2024
- Total Revenue
- 22.87
- Selling/ General/ Admin Expenses Total
- 15.62
- Depreciation/ Amortization
- 2.92
- Other Operating Expenses Total
- 0.03
- Total Operating Expense
- 21.33
- Operating Income
- 1.54
- Net Income Before Taxes
- 2.85
- Net Income
- 2.36
- Diluted Normalized EPS
- 1.01
- Period
- 2024
- Total Assets
- 121.45
- Total Liabilities
- 25.18
- Total Equity
- 96.27
- Tangible Book Valueper Share Common Eq
- 41.14
- Period
- 2024
- Cashfrom Operating Activities
- 7.18
- Cashfrom Investing Activities
- -0.63
- Cashfrom Financing Activities
- -7.62
- Net Changein Cash
- -1.08
- Period
- 2023
- Total Revenue
- 18.94
- Selling/ General/ Admin Expenses Total
- 3.46
- Depreciation/ Amortization
- 2.93
- Other Operating Expenses Total
- 12.67
- Total Operating Expense
- 21.64
- Operating Income
- -2.69
- Net Income Before Taxes
- -2.57
- Net Income
- -2.57
- Diluted Normalized EPS
- -1.1
- Period
- 2023
- Total Assets
- 128.03
- Total Liabilities
- 34.12
- Total Equity
- 93.92
- Tangible Book Valueper Share Common Eq
- 40.19
- Period
- 2023
- Cashfrom Operating Activities
- 4.09
- Cashfrom Investing Activities
- -0.07
- Cashfrom Financing Activities
- -2.03
- Net Changein Cash
- 1.99
- Period
- 2022
- Total Revenue
- 39.73
- Selling/ General/ Admin Expenses Total
- 5.95
- Depreciation/ Amortization
- 2.9
- Other Operating Expenses Total
- 5.74
- Total Operating Expense
- 34.37
- Operating Income
- 5.37
- Net Income Before Taxes
- 2.84
- Net Income
- 2.37
- Diluted Normalized EPS
- 1.12
- Period
- 2022
- Total Assets
- 129.12
- Total Liabilities
- 32.55
- Total Equity
- 96.56
- Tangible Book Valueper Share Common Eq
- 41.32
- Period
- 2022
- Cashfrom Operating Activities
- -62.63
- Cashfrom Investing Activities
- -1.87
- Cashfrom Financing Activities
- 62.64
- Net Changein Cash
- -1.86
- Period
- 2021
- Total Revenue
- 40.69
- Selling/ General/ Admin Expenses Total
- 7.61
- Depreciation/ Amortization
- 2.61
- Other Operating Expenses Total
- 0.07
- Total Operating Expense
- 33.38
- Operating Income
- 7.31
- Net Income Before Taxes
- 4.11
- Net Income
- 4.11
- Diluted Normalized EPS
- 1.76
- Period
- 2021
- Total Assets
- 65.08
- Total Liabilities
- 35.84
- Total Equity
- 29.25
- Tangible Book Valueper Share Common Eq
- 12.5
- Period
- 2021
- Cashfrom Operating Activities
- 14.5
- Cashfrom Investing Activities
- -7.98
- Cashfrom Financing Activities
- -7.97
- Net Changein Cash
- -1.44
- Period
- 2020
- Total Revenue
- 27.23
- Selling/ General/ Admin Expenses Total
- 6.09
- Depreciation/ Amortization
- 2.56
- Other Operating Expenses Total
- 0.01
- Total Operating Expense
- 21.19
- Operating Income
- 6.04
- Net Income Before Taxes
- 1.38
- Net Income
- 1.38
- Diluted Normalized EPS
- 0.59
- Period
- 2020
- Total Assets
- 60.05
- Total Liabilities
- 35.86
- Total Equity
- 24.19
- Tangible Book Valueper Share Common Eq
- 10.34
- Period
- 2020
- Cashfrom Operating Activities
- -0.96
- Cashfrom Investing Activities
- -0.24
- Cashfrom Financing Activities
- 4.16
- Net Changein Cash
- 2.96
- Period
- 2019
- Total Revenue
- 27.67
- Selling/ General/ Admin Expenses Total
- 5.61
- Depreciation/ Amortization
- 2.54
- Other Operating Expenses Total
- 0.04
- Total Operating Expense
- 20.7
- Operating Income
- 6.97
- Net Income Before Taxes
- 1.36
- Net Income
- 1.36
- Diluted Normalized EPS
- 0.58
- Period
- 2019
- Total Assets
- 54.05
- Total Liabilities
- 38.69
- Total Equity
- 15.36
- Tangible Book Valueper Share Common Eq
- 6.56
- Period
- 2019
- Cashfrom Operating Activities
- 10.12
- Cashfrom Investing Activities
- -0.31
- Cashfrom Financing Activities
- -9.3
- Net Changein Cash
- 0.51
- Period
- 2025-03-31
- Total Revenue
- 10.28
- Selling/ General/ Admin Expenses Total
- 3.46
- Depreciation/ Amortization
- 1.37
- Other Operating Expenses Total
- 5.67
- Total Operating Expense
- 10.93
- Operating Income
- -0.64
- Net Income Before Taxes
- 1.93
- Net Income
- 1.65
- Diluted Normalized EPS
- 0.36
- Period
- 2025-03-31
- Total Assets
- 116.05
- Total Liabilities
- 16.51
- Total Equity
- 99.54
- Tangible Book Valueper Share Common Eq
- 42.54
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 9.19
- Cashfrom Investing Activities
- -1.38
- Cashfrom Financing Activities
- -7.2
- Net Changein Cash
- 0.61
- Period
- 2024-09-30
- Total Revenue
- 12.36
- Selling/ General/ Admin Expenses Total
- 1.81
- Depreciation/ Amortization
- 1.58
- Other Operating Expenses Total
- 4.94
- Total Operating Expense
- 9.47
- Operating Income
- 2.9
- Net Income Before Taxes
- 1.94
- Net Income
- 1.62
- Diluted Normalized EPS
- 0.69
- Period
- 2024-09-30
- Total Assets
- 120.03
- Total Liabilities
- 22.13
- Total Equity
- 97.89
- Tangible Book Valueper Share Common Eq
- 41.89
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 3.66
- Cashfrom Investing Activities
- -0.91
- Cashfrom Financing Activities
- -4.02
- Net Changein Cash
- -1.27
- Period
- 2024-03-31
- Total Revenue
- 12.07
- Selling/ General/ Admin Expenses Total
- 1.78
- Depreciation/ Amortization
- 1.45
- Other Operating Expenses Total
- 5.25
- Total Operating Expense
- 9.89
- Operating Income
- 2.18
- Net Income Before Taxes
- 2.33
- Net Income
- 1.93
- Diluted Normalized EPS
- 0.84
- Period
- 2024-03-31
- Total Assets
- 121.45
- Total Liabilities
- 25.18
- Total Equity
- 96.27
- Tangible Book Valueper Share Common Eq
- 41.14
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 7.18
- Cashfrom Investing Activities
- -0.63
- Cashfrom Financing Activities
- -7.62
- Net Changein Cash
- -1.08
- Period
- 2023-09-30
- Total Revenue
- 10.8
- Selling/ General/ Admin Expenses Total
- 1.7
- Depreciation/ Amortization
- 1.47
- Other Operating Expenses Total
- 6.92
- Total Operating Expense
- 11.44
- Operating Income
- -0.64
- Net Income Before Taxes
- 0.51
- Net Income
- 0.42
- Diluted Normalized EPS
- 0.18
- Period
- 2023-09-30
- Total Assets
- 122.63
- Total Liabilities
- 28.29
- Total Equity
- 94.34
- Tangible Book Valueper Share Common Eq
- 40.32
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 3.76
- Cashfrom Investing Activities
- -0.47
- Cashfrom Financing Activities
- -5.37
- Net Changein Cash
- -2.09
- Period
- 2023-03-31
- Total Revenue
- 7.41
- Selling/ General/ Admin Expenses Total
- 1.67
- Depreciation/ Amortization
- 1.49
- Other Operating Expenses Total
- 4.9
- Total Operating Expense
- 9.4
- Operating Income
- -1.99
- Net Income Before Taxes
- -2.1
- Net Income
- -2.1
- Diluted Normalized EPS
- -0.91
- Period
- 2023-03-31
- Total Assets
- 128.03
- Total Liabilities
- 34.12
- Total Equity
- 93.92
- Tangible Book Valueper Share Common Eq
- 40.19
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 4.09
- Cashfrom Investing Activities
- -0.07
- Cashfrom Financing Activities
- -2.03
- Net Changein Cash
- 1.99
- Period
- 2022-09-30
- Total Revenue
- 11.54
- Selling/ General/ Admin Expenses Total
- 1.79
- Depreciation/ Amortization
- 1.44
- Other Operating Expenses Total
- 4.42
- Total Operating Expense
- 12.24
- Operating Income
- -0.71
- Net Income Before Taxes
- -0.47
- Net Income
- -0.47
- Diluted Normalized EPS
- -0.2
- Period
- 2022-09-30
- Total Assets
- 130.12
- Total Liabilities
- 34.03
- Total Equity
- 96.09
- Tangible Book Valueper Share Common Eq
- 41.12
- Period
- 2022-09-30
- Cashfrom Operating Activities
- -0.89
- Cashfrom Investing Activities
- -0.01
- Cashfrom Financing Activities
- 1.51
- Net Changein Cash
- 0.6
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Aashka Hospitals Technical
Moving Average
SMA
- 5 Day97.86
- 10 Day97.86
- 20 Day97.58
- 50 Day101.51
- 100 Day103.44
- 300 Day106.67
Aashka Hospitals Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Kerala Ayurveda
- 585
- 47.4
- 8.82
- 559
- 250
- 703.9
- Forbes And Company
- 436
- 1.8
- 0.41
- 787.95
- 264.35
- 558.84
- Aashka Hospitals
- 100
- 4
- 4.17
- 126.55
- 88.15
- 234
- Lotus Eye Hospital And Institute
- 71.03
- -0.65
- -0.91
- 91
- 53.44
- 148.09
- Fortis Malar Hospitals
- 72.62
- 0.21
- 0.29
- 98.7
- 51.01
- 135.85
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Kerala Ayurveda
- -
- 68.45
- -33.05
- -3.81
- Forbes And Company
- 24.89
- 2.5
- -36.13
- -7.89
- Aashka Hospitals
- 86.44
- 2.16
- 2.52
- 6.58
- Lotus Eye Hospital And Institute
- 200.14
- 2.48
- 4.39
- 5.68
- Fortis Malar Hospitals
- 347.9
- 4.54
- 3.47
- 4.69
Aashka Hospitals Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 27-May-25
- Audited Results
- 30-Oct-24
- Half Yearly Results
- 30-May-24
- Audited Results
- 09-Nov-23
- Half Yearly Results
- 30-May-23
- Audited Results
- 14-Apr-23
- Half Yearly Results
- 18-Jan-23
- Audited Results
- 13-Nov-21
- Half Yearly Results
- Meeting Date
- Announced on
- Purpose
- 01-Mar-25
- 28-Jan-25
- POM
- 23-Aug-24
- 31-Jul-24
- AGM
- 29-Sept-23
- 31-Aug-23
- AGM
- 28-Apr-23
- 05-Apr-23
- AGM
